Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

X4 Pharmaceuticals (XFOR) Change in Acquisitions & Divestments (2023 - 2025)

X4 Pharmaceuticals' Change in Acquisitions & Divestments history spans 3 years, with the latest figure at $18.8 million for Q4 2025.

  • For Q4 2025, Change in Acquisitions & Divestments rose 32.04% year-over-year to $18.8 million; the TTM value through Dec 2025 reached $74.5 million, up 181.82%, while the annual FY2025 figure was $74.5 million, 181.82% up from the prior year.
  • Change in Acquisitions & Divestments reached $18.8 million in Q4 2025 per XFOR's latest filing, up from $15.9 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $28.2 million in Q2 2025 to a low of $1.0 million in Q3 2023.
  • Average Change in Acquisitions & Divestments over 3 years is $10.3 million, with a median of $8.5 million recorded in 2024.
  • Peak YoY movement for Change in Acquisitions & Divestments: surged 1320.0% in 2024, then skyrocketed 32.04% in 2025.
  • A 3-year view of Change in Acquisitions & Divestments shows it stood at $1.0 million in 2023, then soared by 1320.0% to $14.2 million in 2024, then soared by 32.04% to $18.8 million in 2025.
  • Per Business Quant, the three most recent readings for XFOR's Change in Acquisitions & Divestments are $18.8 million (Q4 2025), $15.9 million (Q3 2025), and $28.2 million (Q2 2025).